Cross Country Healthcare (CCRN) Tops Q2 EPS by 7c, Q3 Guidance Beats

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.47, $0.07 better than the analyst estimate of $0.40. Revenue for the quarter came in at $331.83 million versus the consensus estimate of $297.34 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2021 EPS of $0.30-$0.35, versus the consensus of $0.22. Cross Country Healthcare sees Q3 2021 revenue of $310-320 million, versus the consensus of $253.3 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
• Anterix Inc. (ATEX) Tops Q4 EPS by 152c